| 中文名 | 7-甲氧基-8-甲基-4-氧代-1,4-二氢喹啉-3-羧酸乙酯 |
|---|---|
| 英文名 | ethyl 7-methoxy-8-methyl-4-oxo-1H-quinoline-3-carboxylate |
| 中文别名 |
4-羟基-7-甲氧基-8-甲基-3-喹啉羧酸乙酯
3-喹啉羧酸,4-羟基-7-甲氧基-8-甲基-乙酯 |
| 英文别名 |
Ethyl 7-methoxy-8-methyl-4-oxo-1,4-dihydroquinoline-3-cboxylate
3-Quinolinecarboxylic acid,4-hydroxy-7-methoxy-8-methyl-,ethyl ester 3-Quinolinecboxylic acid, 4-hydroxy-7-methoxy-8-methyl-, ethyl ester ethyl 4-hydroxy-7-methoxy-8-methylquinoline-3-cboxylate Ethyl 4-hydroxy-7-methoxy-8-methyl-3-quinolinecboxylate ethyl 4-hydroxy-7-methoxy-8-methylquinoline-3-carboxylate |
| 分子式 | C14H15NO4 |
|---|---|
| 分子量 | 261.27300 |
| 精确质量 | 261.10000 |
| PSA | 68.39000 |
| LogP | 2.02180 |
|
~58%
922520-00-1 |
| 文献:TIBOTEC PHARMACEUTICALS LTD.; MEDIVIR AB Patent: WO2007/14926 A1, 2007 ; Location in patent: Page/Page column 82-83 ; |